Brief: Viracta Therapeutics Reports Q3 Loss Per Share Of $0.40

Viracta Therapeutics

10/11/2021 13:12

Nov 10 (Reuters) - Viracta Therapeutics Inc  VIRX.O :
    * VIRACTA THERAPEUTICS REPORTS THIRD QUARTER 2021 FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
    * Q3 LOSS PER SHARE $0.40
    * EXPECTS TO END 2021 WITH OVER$100 MILLION IN CASH AND CASH
EQUIVALENTS, WHICH IT EXPECTS TO SUFFICIENTLY FUND ITS
OPERATIONS INTO 2024, EXCLUDING ADDITIONAL BORROWINGS UNDER $50
MILLION CREDIT FACILITY

Source text for Eikon:  ID:nPnbYQBX7a 
Further company coverage:  VIRX.O 

 ((Reuters.Briefs@thomsonreuters.com;))